Following the emergence of many blood transfusion-associated diseases, novel passive cell separation technologies, such as microfluidic devices, are increasingly designed and optimized to separate red cells (RBCs) white (WBCs) from whole blood. These systems allow for rapid diagnosis diseases without relying on complicated expensive hematology instruments flow microscopes, coagulation analyzers...